Glendon E. French III - 01 Mar 2022 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
President and CEO, Director
Signature
/s/ Lauren Cristina, Attorney-in-Fact for Glendon E. French
Issuer symbol
LUNG
Transactions as of
01 Mar 2022
Net transactions value
-$29,330
Form type
4
Filing time
03 Mar 2022, 17:03:42 UTC
Previous filing
22 Feb 2022
Next filing
18 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Sale $29,330 -1,132 -0.11% $25.91 1,062,817 01 Mar 2022 Direct F1
transaction LUNG Common Stock Award $0 +69,700 +6.6% $0.000000 1,132,517 01 Mar 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LUNG Employee Stock Option (right to buy) Award $0 +154,600 $0.000000 154,600 01 Mar 2022 Common Stock 154,600 $26.56 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021.
F2 Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2022.
F3 The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2022.